Sarepta Therapeutics, Inc. — Director's Dealing 2021

Dec 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2021-12-10

Reporting Person: GRAY MARY ANN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-10	Common Stock	M	967	$0.00	Acquired	9403	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-10	Restricted Stock Units	$	M	967	Disposed		Common Stock (967)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock.

F2: The third out of three annual equal installments of restricted stock units vested on December 10, 2021.